Clinical Trials

2 enrolled

Colonic Neoplasms

NCT05076513 2026-03-09

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

42 enrolled

Glioblastoma, Glioma

NCT05182905 2026-03-09

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

97 enrolled

Glioblastoma, Glioma

NCT02812420 2026-03-05

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery

54 enrolled

Hydronephrosis, Ureteral Neoplasms, Urethral Neoplasms

NCT03128866 2026-03-05

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

80 enrolled

Pelvic Mass

NCT03832569 2026-03-05

Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors

17 enrolled

Pathologic Complete Response

NCT03164486 2026-02-27

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

BreastGastrointestinalThoracic

27 enrolled

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07435415 2026-02-27

Local Injection Methylene Blue Combined With Radiation in HNSCC Patients

10 enrolled

Head & Neck

Head and Neck Neoplasms

NCT03943173 2026-02-25

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

15 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03334500 2026-02-20

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT04993261 2026-02-19

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

71 enrolled

Endocrine

Carcinoid Tumor, Serotonin Syndrome

NCT03970226 2026-02-17

Tocilizumab in Children With ACP

9 enrolled

Craniopharyngioma

NCT05160597 2026-02-12

Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy

30 enrolled

Prostatic Neoplasms

NCT03387553 2026-02-09

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

31 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

34 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05406700 2026-02-09

Niraparib In Recurrent IDH 1/2 Gliomas

16 enrolled

Glioma

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

22 enrolled

Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT03543969 2026-02-05

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

14 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT02603887 2026-01-29

Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma

20 enrolled 12 charts

Plasma cell

Smoldering Multiple Myeloma

NCT05477823 2026-01-28

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT04018053 2026-01-27

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

16 enrolled 3 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04733027 2026-01-22

Clever Peptide

57 enrolled

Other solid neoplasm

Metastatic Solid Tumor Cancer

NCT04040088 2026-01-08

An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

Ganglioneuroma, Neuroblastoma, Ganglioneuroblastoma

NCT04514029 2026-01-08

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

37 enrolled

Lymphoid

Lymphoma, Neurotoxicity Syndromes

NCT05108428 2026-01-08

Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

Colonic Neoplasms, Rectal Neoplasms

NCT05245682 2026-01-08

Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer

Head & NeckOther solid neoplasm

10 enrolled 8 charts

Head and Neck Carcinoma of Unknown Primary

NCT02210117 2026-01-07

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

104 enrolled

Carcinoma, Renal Cell

NCT04656535 2026-01-07

AB154 Combined With AB122 for Recurrent Glioblastoma

46 enrolled

Glioblastoma, Recurrence

NCT05091866 2026-01-07

Natural Progesterone for the Treatment of Recurrent Glioblastoma

4 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT05336266 2026-01-06

KetoROCX

28 enrolled

Pancreatic Neoplasms

NCT04370483 2026-01-05

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma

1 enrolled

Plasma cell

Smoldering Multiple Myeloma

NCT05560399 2026-01-02

CC-220

7 enrolled

Plasma cell

Multiple Myeloma

NCT05868486 2026-01-02

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

100 enrolled

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT04126824 2025-12-17

Effect of Addition of Steroids on Duration of Analgesia

28 enrolled

Leiomyoma, Adenomyosis

NCT05798507 2025-12-15

Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma

14 enrolled

Glioblastoma

NCT02415621 2025-12-04

Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer

19 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT03511196 2025-12-04

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

17 enrolled

Prostatic Neoplasms

NCT06866548 2025-12-04

Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

7 enrolled

Insulin-Like Growth Factor I, Resistance To, Neoplasm Metastasis, Prostatic Neoplasms

NCT03541720 2025-12-03

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

13 enrolled

CNSEndocrine

Neuroblastoma, Pheochromocytoma

NCT06209567 2025-12-03

A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors

11 enrolled

Brain Neoplasms, Glioma

NCT03837821 2025-11-18

CLONEVO

Urinary Bladder Neoplasms

NCT05045027 2025-11-14

Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma

36 enrolled

Glioma

NCT01098955 2025-11-10

Smoking Cessation Treatment for Head & Neck Cancer Patients

51 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplasms, Smoking Cessation

NCT05047965 2025-11-03

An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

65 enrolled

Prostatic Neoplasms

NCT02744053 2025-10-20

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

96 enrolled

Breast

Triple Negative Breast Neoplasms

NCT02659241 2025-10-14

Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

38 enrolled

Gynecologic

Carcinoma, Fallopian Tube Neoplasms

NCT02790853 2025-10-14

Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders

63 enrolled

Head & Neck

Mouth Diseases, Mouth Neoplasms

NCT05047913 2025-10-14

Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR

CNSGynecologic

Brain Neoplasms, Uterine Cervical Neoplasms

NCT04857684 2025-10-01

SBRT + Atezolizumab + Bevacizumab in Resectable HCC

Carcinoma, Hepatocellular

NCT05488366 2025-09-22

Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma